UNIS News Alert Unilife Corp (UNIS) 3.19 12/25/2014 12:38:42

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Unilife Corp (UNIS) 3.19 $UNIS

Unilife Hires Intel Marketing Executive Kevin Sellers as Senior Vice President of Marketing and Communications
PR Newswire - Thu Dec 11, 8:00AM CST
Unilife Corporation (NASDAQ: UNIS and ASX: UNS), a developer and supplier of injectable drug delivery systems, today announced the appointment of Kevin Sellers, a veteran marketing and communications executive at Intel Corporation, to the post of Senior Vice President, Marketing and Communications. Sellers will report to Unilife Chairman and CEO Alan Shortall, with responsibility for investor relations, global marketing and public relations
UNIS: 3.19 (+0.03), INTC: 37.44 (+0.01)

Unilife Signs Long-Term Commercial Supply Agreement for Use of Depot-ject(TM) Delivery System with Approved Ocular Injection Drug
PR Newswire - Tue Dec 02, 7:00AM CST
Unilife Corporation (NASDAQ: UNIS and ASX: UNS), a developer and supplier of injectable drug delivery systems, announced today the signing of a worldwide 10 year Commercial Supply Agreement with a global pharmaceutical company for the use of the Depot-ject(TM) delivery system with an approved ocular injection therapy.
UNIS: 3.19 (+0.03)

Unilife to Present at the Piper Jaffray 26th Annual Healthcare Conference on December 2nd
PR Newswire - Tue Nov 25, 3:05PM CST
Unilife Corporation (NASDAQ:UNIS, ASX: UNS), a designer, manufacturer and supplier of injectable drug delivery systems, today announced that its Chairman and CEO, Alan Shortall, is scheduled to present at the Piper Jaffray 26th Annual Healthcare Conference at the New York Palace Hotel at 8:30 a.m. EST on Tuesday, December 2, 2014.
UNIS: 3.19 (+0.03)

Unilife and Flextronics Enter Into Global Strategic Alliance
PR Newswire - Thu Nov 13, 7:30AM CST
Unilife Corporation (NASDAQ:UNIS, ASX: UNS), a designer, manufacturer and supplier of injectable drug delivery systems, today announced the signing of a Global Strategic Alliance Agreement with Flextronics (NASDAQ: FLEX), a leading end-to-end supply chain solutions company, as its global strategic partner to further expand the production capacity and scale-up capability of Unilife's product portfolio.
FLEX: 11.25 (+0.11), UNIS: 3.19 (+0.03)

Midday gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 11:45AM CST

FSM: 4.31 (+0.10), HEAR: 2.98 (+0.01), JRJC: 5.81 (-0.11), CVO: 2.13 (-0.03), AAOI: 10.75 (-0.05), UNIS: 3.19 (+0.03), HIIQ: 7.51 (-0.16), CYAN: 7.00 (+0.50), PTX: 9.05 (+0.28), TRMR: 2.74 (-0.08), PRKR: 0.90 (+0.04), SUMR: 3.10 (+0.06), VSLR: 8.97 (+0.18), RVP: 4.84 (+0.19), ASCMA: 53.62 (+0.92), ICUI: 83.38 (+1.63), CALL: 7.83 (-0.07), DMD: 5.96 (-0.09), AST: 3.22 (+0.01), ASEI: 51.61 (+0.05)

Unilife Corporation Submits its 10-Q for Filing
PR Newswire - Tue Nov 11, 8:18AM CST
Unilife Corporation ("Unilife" or "Company" (NASDAQ: UNIS; ASX: UNS), a developer and supplier of injectable drug delivery systems, today announced that it has submitted for filing its 10-Q report for the first quarter of Fiscal Year 2015 ending September 30, 2014. Due to Veteran's Day in the U.S., the Securities Exchange Commission ("SEC)" is closed today. The 10-Q will be available publicly on Wednesday morning prior to market open. As an interim measure, the Company has placed the 10-Q onto its website where it may be accessed at http://ir.unilife.com or via this link.
UNIS: 3.19 (+0.03)

Unilife beats 1Q profit forecasts
Automated Insights - Tue Nov 11, 4:11AM CST
YORK, Pa. (AP) _ Unilife Corp. (UNIS) on Tuesday reported a loss of $22.3 million in its fiscal first quarter.
UNIS: 3.19 (+0.03)

Unilife's (UNIS) CEO Alan Shortall on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 10, 7:55PM CST

UNIS: 3.19 (+0.03)

/C O R R E C T I O N -- Unilife Corporation/
PR Newswire - Mon Nov 10, 4:58PM CST
In the news release, Unilife Corporation Announces Financial Results For the First Quarter of Fiscal Year 2015, issued 10-Nov-2014 by Unilife Corporation over PR Newswire, we are advised by the company that there were multiple changes throughout the release. The complete, corrected release follows:
UNIS: 3.19 (+0.03)

Unilife Corporation misses by $0.01, misses on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 3:25PM CST

UNIS: 3.19 (+0.03)

Unilife (UNIS) Q1 2015 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Mon Nov 10, 3:25PM CST

UNIS: 3.19 (+0.03)

Unilife Corporation Announces Financial Results For the First Quarter of Fiscal Year 2015
PR Newswire - Mon Nov 10, 3:15PM CST
Unilife Corporation ("Unilife" or "Company" (NASDAQ: UNIS; ASX: UNS), a developer and supplier of injectable drug delivery systems, today announced its financial results for the first quarter of Fiscal Year 2015 ending September 30, 2014.
UNIS: 3.19 (+0.03)

The Zacks Analyst Blog Highlights: AbbVie, Shire, Medtronic, Unilife and Derma Sciences
PR Newswire - Fri Nov 07, 8:30AM CST
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the AbbVie Inc. (NYSE:ABBV-Free Report), Shire plc (Nasdaq:SHPG-Free Report), Medtronic Inc. (NYSE:MDT-Free Report), Unilife Corporation (Nasdaq:UNIS-Free Report) and Derma Sciences Inc. (Nasdaq SCI-Free Report).
DSCI: 9.08 (+0.43), UNIS: 3.19 (+0.03), MDT: 74.08 (+0.31), SHPG: 209.29 (+0.07)

Should You Buy Unilife Corporation (UNIS) Ahead of Earnings? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 7:51AM CST
Investors are always looking for stocks that are poised to beat at earnings season and Unilife Corporation (UNIS) may be one such company.
UNIS: 3.19 (+0.03)

Top 2 MedTech Stocks, Poised to Gain on Earnings this Season - Earnings ESP
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 9:36AM CST
Medical device is one of such sectors which are projected to be highly affected by the midterm election results.
DSCI: 9.08 (+0.43), MDT: 74.08 (+0.31), UNIS: 3.19 (+0.03), COV: 103.35 (+0.57), SHPG: 209.29 (+0.07), ABBV: 66.21 (+1.86), WAG: 76.67 (+0.16)

Unilfe: New Contracts Will Triple Share Price
RightEdge Analytics - Seeking Alpha - Tue Nov 04, 7:43AM CST
Update: This article is to update the recent announcements and run up in share price since the last article that we published on Unilife (NASDAQ: UNIS ) on September 19, 2014 . Since this article UNIS has increased in value by about 50%. This is...
UNIS: 3.19 (+0.03)

Unilife Corporation To Announce Financial Results For Fiscal Year 2015 First Quarter On Monday, November 10, 2014
PR Newswire - Thu Oct 30, 5:00PM CDT
Unilife Corporation ("Unilife" or "Company" (NASDAQ: UNIS; ASX: UNS) announced today that it intends to release its financial results for the fiscal 2015 first quarter ended September 30, 2014 after market trading ends on Monday, November 10, 2014.
UNIS: 3.19 (+0.03)

Unilife Up 6.6%, Shares Break Through Resistance (UNIS)
Comtex SmarTrend(R) - Wed Oct 29, 10:08AM CDT
Unilife (NASDAQ:UNIS) is one of today's best performing low-priced stocks, up 6.6% to $3.85 on 1.2x average daily volume. Unilife has traded 1.9 million shares thus far today, vs. average volume of 1.6 million shares per day. The stock has outperformed the Dow (6.6% to the Dow's -0.0%) and outperformed the S&P 500 (6.6% to the S&P's -0.0%) during today's trading.
UNIS: 3.19 (+0.03)

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 8:15AM CDT

CAMT: 3.05 (+0.03), ORB: 26.89 (+0.23), UNIS: 3.19 (+0.03), ALLY: 23.87 (-0.02), FB: 80.77 (+0.16), AMCC: 6.63 (+0.09), INVN: 16.22 (+0.27), AKS: 5.76 (+0.11), NBG: 1.95 (+0.06), RFMD: 16.59 (+0.29), BLDP: 1.77 (+0.01), CARA: 9.78 (+0.02), GT: 28.22 (-0.05), HIVE: 4.82 (-0.02), MCGC: 3.95 (+0.02), IBIO: 0.68 (-0.04), BIOS: 6.37 (unch), UBA: 22.46 (-0.04), ARCP: 8.33 (unch), SNY: 46.35 (+0.50), STM: 7.69 (+0.09), X: 26.51 (+0.11)

Upgrade Alert for Unilife (UNIS)
Comtex SmarTrend(R) - Wed Oct 15, 7:03AM CDT
Unilife (NASDAQ:UNIS) was upgraded from Neutral to Buy at Ladenburg today. The stock closed yesterday at $3.37 on volume of 2.0 million shares, above average daily volume of 1.2 million. Unilife Corporation designs and manufactures medical devices. The Company produces retractable syringes. Unilife markets its products to pharmaceutical manufacturers, suppliers of medical equipment to healthcare facilities, and patients who self-administer prescription medication.
UNIS: 3.19 (+0.03)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

ECW Puts $52 Million Behind Learning Through Crisis

Updated Category News Views 66

A reserve fund for a classroom is not glamorous, but it may be the smartest detail in this whole $52 million commitment. Education Cannot Wait has announced support for more than 300,000 children in Lebanon, Myanmar and South Sudan, where war, flooding and displacement have ripped ordinary schooling apart. The money is meant to restore learning, provide catch-up classes...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 22

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
YYForce Security Win Adds Recurring Singapore Revenue Base

Updated Category News Views 160

A retail-property security mandate rarely makes anyone pound the table, and frankly it should not. Still, YYForce has landed a tangible two-year contract in Singapore worth roughly S$831,120, with subsidiary Uniforce Security Services set to begin work on December 1, 2026. For NASDAQ:YFOR investors, this is the kind of small, operationally real win that deserves a sober...

Continue Reading
ASA’s 2026 Grants Push Dermatology Into New Terrain

Updated Category News Views 58

Thirteen Small Bets With Serious Human Stakes Skin science rarely gets the splashy headlines, yet it touches a staggering number of people and carries some very stubborn unanswered questions. American Skin Association’s 2026 grant class puts 13 awards across skin cancer and dermatologic disease, with a noticeable willingness to follow newer clinical terrain rather than...

Continue Reading
Niron's $1.8B Alabama Bet Carries Big Magnet Stakes

Updated Category News Views 54

A Huge Factory Claim Needs More Than Applause A magnet company just tossed a very large number onto Alabama's economic-development table. Niron Magnetics says it plans a $1.8 billion investment in the state that would create 700 jobs. That is not pocket change, not a ribbon-cutting trinket, and not the sort of announcement investors should breeze past between earnings...

Continue Reading
Appian Survey Flags AI Aloneware Maintenance Drag Risk

Updated Category News Views 58

A bot can spit out a feature before lunch, then leave a repair bill nobody budgeted for. That is the uncomfortable issue behind Appian's new research on AI-assisted software development: speed is easy to celebrate, while ownership gets shoved into a dark corner until something breaks. Appian said on November 20, 2026, that two-thirds of surveyed AI decision-makers and IT...

Continue Reading
Sogroya Approval Broadens Novo's Pediatric Growth Franchise

Updated Category News Views 75

Seven fewer injections every week is the real headline behind Novo Nordisk's latest FDA clearance, not some flashy efficacy leap. On November 20, 2026, the company said Sogroya, its once-weekly long-acting growth hormone, won approval for children aged 2.5 and older with growth failure associated with Turner syndrome. That matters because treatment can stretch over years,...

Continue Reading
PCS Rental Prep Is About Control Before Distance Hits

Updated Category News Views 82

A vacant house can turn into a long-distance headache with startling speed. For military homeowners preparing for a PCS move, the useful point in Rhonda Leahy's guidance is not glamorous: settle the boring operational stuff before the moving boxes, travel orders, and new-duty-station chaos swallow the calendar. Renting out a former home is not merely collecting enough...

Continue Reading
Mobile Core's Cost Crunch Favors Telecom's Big Three

Updated Category News Views 67

Server bills have finally crashed the party in mobile core, and nobody should pretend that is a minor inconvenience. Dell'Oro Group's 3Q 2026 read is blunt: Mobile Core Network revenue growth was lackluster because 5G spending came in below expectations, while higher server costs pushed operators to reshuffle priorities, postpone projects, and keep 4G core gear alive...

Continue Reading
Why Brief Chiropractic Visits Still Need Clear Expectations

Updated Category News Views 76

A few minutes on the table can sound almost suspiciously brisk when somebody is dealing with a stiff neck, sore back, or nagging joint discomfort. Yet that is the central point in Dr. Craig Peterson's explanation for HelloNation: the adjustment itself may be brief, while the value of a chiropractor visit depends on a focused assessment, appropriate technique, and whether...

Continue Reading

Top 5 Most Recently Viewed Articles

Organon & Co. Class Action Lawsuit: Key Details You Should Know

Updated Category News Views 221

Overview of the Class Action Lawsuit Against Organon & Co. The latest developments in the class action lawsuit regarding Organon & Co. (NYSE: OGN) have attracted attention from investors. The lawsuit is aimed at representing purchasers of Organon's publicly traded securities during a specific time frame. Robbins Geller Rudman & Dowd LLP has taken the lead in filing this...

Continue Reading
JINRO Partners with BTS's V: A Strategic Move

Updated Category News Views 25

What's Brewing Between JINRO and BTS's V? Picture this: you're wandering the aisles of an international market, see a splashy new bottle of soju, and notice V from BTS smiling from the label. That's right, folks, JINRO, the world's reigning soju brand, has just snagged a partnership with BTS's V to serve up a global brand punch. This move isn't just a pretty face on a...

Continue Reading
Latin Metals Unveils Exciting Spin-Out Plan for Copper Assets

Updated Category News Views 172

Latin Metals Moves Forward with Spin-Out of Peruvian Assets Latin Metals Inc. (TSXV: LMS, OTCQB: LMSQF) is charting a new course by announcing its decision to spin-out certain Peruvian exploration projects into a newly founded subsidiary named Latin Explore. This strategic move aims to unlock value for shareholders while maintaining a robust exploration agenda. Overview...

Continue Reading
McCormick's Resilience Shines Amidst Economic Challenges

Updated Category News Views 66

McCormick Challenges and Growth Strategy McCormick & Company, Inc. (NASDAQ: MKC) recently announced its third-quarter earnings, revealing a solid financial performance, even in a tough consumer environment. The company achieved a 1% volume growth in its Consumer segment and steady sales in its Flavor Solutions segment, showcasing a strong market presence despite...

Continue Reading
Goodyear's Financial Performance Amidst Industry Challenges

Updated Category News Views 248

Understanding Goodyear's Recent Earnings Report Goodyear Tire & Rubber Co (NASDAQ: GT) has reported its recent financial results, particularly highlighting the challenges faced during the second quarter of their fiscal year 2025. This period proved to be quite turbulent after the closing bell, reflecting considerable disruptions in their operating environment that...

Continue Reading